Scientists at the University of Edinburgh have identified new drug targets within bacterial cells that could help overcome ...
Merck (known as MSD outside the United States and Canada) has ended its development partnership with Dr Falk Pharma ...
Lilly will also gain exclusive access to MeiraGTx’s gene therapy platform technologies, including novel intravitreal capsids ...
Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role ...
AstraZeneca has announced positive results from its Bax24 trial of baxdrostat, an investigational treatment for hypertension, ...
Merck (known as MSD outside the US and Canada) has entered into a funding agreement with Blackstone Life Sciences to support ...
Cross-functional collaboration is often portrayed as a way to drive innovation. But when done well, another aspect of its ...
Support for first and only high-risk smouldering multiple myeloma treatment came from positive phase 3 trial results ...
In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever ...
The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient ...
At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, ...
The Pfizer bid was chosen by Metsera after a concern was raised about US antitrust laws regarding the Novo Nordisk offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results